全文获取类型
收费全文 | 16360篇 |
免费 | 1543篇 |
国内免费 | 231篇 |
专业分类
耳鼻咽喉 | 80篇 |
儿科学 | 666篇 |
妇产科学 | 237篇 |
基础医学 | 862篇 |
口腔科学 | 518篇 |
临床医学 | 1951篇 |
内科学 | 2003篇 |
皮肤病学 | 89篇 |
神经病学 | 1514篇 |
特种医学 | 192篇 |
外科学 | 1014篇 |
综合类 | 1715篇 |
现状与发展 | 1篇 |
预防医学 | 4917篇 |
眼科学 | 96篇 |
药学 | 791篇 |
29篇 | |
中国医学 | 366篇 |
肿瘤学 | 1093篇 |
出版年
2024年 | 41篇 |
2023年 | 346篇 |
2022年 | 491篇 |
2021年 | 879篇 |
2020年 | 799篇 |
2019年 | 721篇 |
2018年 | 676篇 |
2017年 | 683篇 |
2016年 | 635篇 |
2015年 | 602篇 |
2014年 | 1111篇 |
2013年 | 1302篇 |
2012年 | 990篇 |
2011年 | 1077篇 |
2010年 | 804篇 |
2009年 | 903篇 |
2008年 | 900篇 |
2007年 | 844篇 |
2006年 | 627篇 |
2005年 | 508篇 |
2004年 | 435篇 |
2003年 | 378篇 |
2002年 | 310篇 |
2001年 | 255篇 |
2000年 | 235篇 |
1999年 | 183篇 |
1998年 | 174篇 |
1997年 | 138篇 |
1996年 | 121篇 |
1995年 | 130篇 |
1994年 | 92篇 |
1993年 | 94篇 |
1992年 | 85篇 |
1991年 | 70篇 |
1990年 | 58篇 |
1989年 | 63篇 |
1988年 | 57篇 |
1987年 | 36篇 |
1986年 | 32篇 |
1985年 | 59篇 |
1984年 | 37篇 |
1983年 | 27篇 |
1982年 | 25篇 |
1981年 | 23篇 |
1980年 | 17篇 |
1979年 | 16篇 |
1978年 | 12篇 |
1977年 | 7篇 |
1976年 | 7篇 |
1972年 | 6篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
11.
《Journal of the American Medical Directors Association》2022,23(1):161-164
ObjectivesAs more countries are implementing measures to address Alzheimer’s disease (AD), it is essential to update the available knowledge on the relationship between economic status and mortality in patients with AD. This study examined the influence of economic status on mortality in Japanese individuals with AD using a medical claims dataset.DesignThis was a retrospective cohort study.Setting and ParticipantsMedical claims data from April 2014 to March 2019 were obtained from 13 local cities participating in the Longevity Improvement and Fair Evidence study. The inclusion criteria were patients aged 65 years and older who were newly diagnosed with AD during the study period.MethodsThe outcome was death during the follow-up period. We assessed economic status by household income (middle to high income and low income); data were obtained from the use of the Medical Expenditure Ceiling Application and Standard Copayment Reduction Card (fee reduction card) when receiving an AD diagnosis, as an indicator of low-income status. We performed multivariate Cox proportional hazards analyses to examine the relationship between economic status and mortality; the model was adjusted for age, sex, the Charlson comorbidity index, and antidementia drug use.ResultsWe identified 39,081 newly diagnosed patients with AD from the Longevity Improvement and Fair Evidence study database (mean age, 83.6 years; female, 67.1%). Of these, 3189 individuals were identified as having a low-income status. After adjusting for possible confounders, low-income status was associated with mortality (hazard ratio, 1.95; 95% confidence interval, 1.84–2.07).Conclusions and ImplicationsLow-income status was associated with substantially poorer prognoses in new AD cases, indicating a need for a thorough examination of medical and nursing care services utilized by low-income individuals with AD and to explore improvement strategies. 相似文献
12.
《Clinical oncology (Royal College of Radiologists (Great Britain))》2022,34(7):472-479
AimsTreatment decisions for older patients with breast cancer are complex and evidence is largely extrapolated from younger populations. Frailty and comorbidity need to be considered. We studied the baseline characteristics and treatment decisions in older patients in Christchurch with breast cancer and assessed survival outcomes and prognostic/discriminatory performance of several tools.Materials and methodsWe searched the Canterbury Breast Cancer Registry and identified patients aged 70 years or older at diagnosis with invasive, non-metastatic breast cancer between 1 June 2009 and 30 June 2015. We retrieved demographics, treatment and outcome information. Overall survival and breast cancer-specific survival were estimated. Tools analysing performance status and comorbidity were assessed for their prognostic and discriminatory power.ResultsIn total, 440 patients were identified. Primary surgery was carried out for 362 patients (82.3%): breast-conserving surgery in 114 (of whom 88.6% received radiation therapy); mastectomy in 248 (of whom 24.6% received radiation). Hormone therapy was given for 265 (71.1%) patients with oestrogen receptor-positive cancers. Two hundred and seventy-four (62.3%) patients received full standard treatment, which was associated with significantly improved 5-year survival and 5-year breast cancer-specific survival. The median estimated overall survival was 8.2 years (95% confidence interval 7.3–9.1 years). Of those who died, 71.3% of deaths were due to causes other than breast cancer or unknown causes. The comorbidity-adjusted life expectancy (CALE) showed partial prognostic accuracy. CALE, Charlson and Eastern Cooperative Oncology Group tools all showed discriminatory value.ConclusionIn this population-based series of older patients with breast cancer, showing high levels of primary and adjuvant treatment, patients were more likely to die of causes other than breast cancer. Performance status and comorbidity tools showed prognostic and discriminatory potential in this population supporting their use in treatment decision making. CALE showed the most potential to improve treatment decisions but requires validation in this population to improve prognostic accuracy. 相似文献
13.
14.
15.
The association between family affluence and smoking among 15‐year‐old adolescents in 33 European countries,Israel and Canada: the role of national wealth 下载免费PDF全文
16.
17.
18.
The difficulty of diagnosing NCSE in clinical practice; external validation of the Salzburg criteria
Rianne J. M. Goselink Jeroen J. van Dillen Marjolein Aerts Johan Arends Charlotte van Asch Inge van der Linden Jaco Pasman Christiaan G. J. Saris Machiel Zwarts Nens van Alfen 《Epilepsia》2019,60(8):e88-e92
To improve the diagnostic accuracy of electroencephalography (EEG) criteria for nonconvulsive status epilepticus (NCSE), external validation of the recently proposed Salzburg criteria is paramount. We performed an external, retrospective, diagnostic accuracy study of the Salzburg criteria, using EEG recordings from patients with and without a clinical suspicion of having NCSE. Of the 191 EEG recordings, 12 (12%) was classified as an NCSE according to the reference standard. In the validation cohort, sensitivity was 67% and specificity was 89%. The positive predictive value was 47% and the negative predictive value was 95%. Ten patients in the control group (n = 93) were false positive, resulting in a specificity of 89.2%. The interrater agreement between the reference standards and between the scorers of the Salzburg criteria was moderate; disagreement occurred mainly in patients with an epileptic encephalopathy. The Salzburg criteria showed a lower diagnostic accuracy in our external validation study than in the original design, suggesting that they cannot replace the current practice of careful weighing of both clinical and EEG information on an individual basis. 相似文献
19.
目的 测定不同来源的4种大宗常用中药饮片中黄曲霉毒素(AFB1、AFB2、AFG1和AFG2)的含量,比较不同基质中药饮片中黄曲霉毒素的分布状况。方法 基于免疫亲和柱净化-高效液相色谱分离-荧光检测器(IAC-HPLC-FLD)方法,分析不同产地共75批中药样品。结果 柏子仁、薏苡仁、决明子及党参共计75批中药饮片中,阳性检出:26批柏子仁(AFs 1.22-46.67 μg·kg-1,AFB1 1.22-31.40 μg·kg-1)、4批薏苡仁(AFs 1.97-41.13 μg·kg-1,AFB1 1.97-36.40 μg·kg-1)、1批决明子(AFs 13.65 μg·kg-1,AFB1 12.60 μg·kg-1),阳性率41%,超标率15%。阳性样品经 LC-MS/MS确证,排除假阳性。4种大宗常用中药饮片柏子仁、薏苡仁、决明子、党参中黄曲霉毒素的污染水平依次降低,阳性检出率分别为77%、29%、7%、0%,表明中药材中黄曲霉毒素的污染状况与药材基质密切相关。结论 针对易污染AFs的中药品种,需进一步加强其污染状况的全面检测分析,为黄曲霉毒素的有效防控以及完善中药的质量标准提供科学依据,从而保障中药用药安全。 相似文献
20.